Comparison of econazole and isoconazole as single dose treatment for vaginal candidosis.
- 1 December 1985
- journal article
- research article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 61 (6), 396-398
- https://doi.org/10.1136/sti.61.6.396
Abstract
In a single blind trial there was no significant difference between econazole (2 .times. 150 mg pessaries) and isoconazole (2 .times. 300 mg pessaries) given as a once only treatment for vaginal candidosis. Cure rates at 14 days were 70.4% for econazole and 77.6% for isconazole, and at 28 days were 63.8% and 64.5% respectively. Though isoconazole was formulated for single dose usage, econazole was formulated for a regimen of one pessary a night for the three nights.This publication has 6 references indexed in Scilit:
- Butoconazole and miconazole in treating vaginal candidiasis.Sexually Transmitted Infections, 1985
- EVOLUTION OF MICROORGANISMS AND ANTIBIOTIC RESISTANCEThe Lancet, 1984
- Clotrimazole and econazole in the treatment of vaginal candidosis. A single-blind comparison.Sexually Transmitted Infections, 1983
- Clinic diagnosis of anaerobic vaginosis (non-specific vaginitis). A practical guide.Sexually Transmitted Infections, 1982
- Laboratory procedures for the isolation of chlamydia trachomatis from the human genital tract.Journal of Clinical Pathology, 1975
- Diagnosis of gonorrhoea by culture on a selective medium containing vancomycin, colistin, nystatin and trimethoprim (VCNT). A comparison with Gram-staining and immunofluorescence.Sexually Transmitted Infections, 1972